{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T00:56:53Z","timestamp":1712365013859},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.0247","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T23:36:47Z","timestamp":1375313807000},"page":"1741-1743","source":"Crossref","is-referenced-by-count":10,"title":["Methemoglobinemia Induced by Trimethoprim-Sulfamethoxazole in a Patient with Systemic Lupus Erythematosus"],"prefix":"10.2169","volume":"52","author":[{"given":"Hidenaga","family":"Kawasumi","sequence":"first","affiliation":[{"name":"Institute of Rheumatology, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Institute of Rheumatology, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Hoshi","sequence":"additional","affiliation":[{"name":"Institute of Rheumatology, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Institute of Rheumatology, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Institute of Rheumatology, Tokyo Women's Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997.","DOI":"10.1002\/art.1780400928"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Damergis JA, Stoker JM, Abadie JL. Methemoglobinemia after sulfametoxazole and trimethoprim. JAMA 249: 590-591, 1983.","DOI":"10.1001\/jama.249.5.590"},{"key":"3","unstructured":"3. Cervera R, Khamashta MA, Font J, et al; European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82: 299-308, 2003."},{"key":"4","unstructured":"4. Goldblatt F, Chambers S, Rahman A, et al. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus 18: 682-689, 2009."},{"key":"5","unstructured":"5. Abu-Shakra M, Urowitz MB, Gladman DD, et al. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 22: 1259-1264, 1995."},{"key":"6","unstructured":"6. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med 34: 646-656, 1999."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fung HT, Lai CH, Wong OF, et al. Two cases of methemoglobinemia following zopiclone ingestion. Clin Toxicol (Phila) 46: 167-170, 2008.","DOI":"10.1080\/15563650701305558"},{"key":"8","unstructured":"8. Turner MD, Karlis V, Glickman RS. The recognition, physiology, and treatment of medication-induced methemoglobinemia: a case report. Anesth Prog 54: 115-117, 2007."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kurian JR, Bajad SU, Miller JL, et al. NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. J Pharmacol Exp Ther 311: 1171-1178, 2004.","DOI":"10.1124\/jpet.104.072389"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rothman N, Hayes RB, Bi W, et al. Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese males. Pharmacogenetics 3: 250-255, 1993.","DOI":"10.1097\/00008571-199310000-00004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Abouraya M, Sacco JC, Hayes K, et al. Dapsone-associated methemoglobinemia in a patient with slow NAT2*5B haplotype and impaired cytochrome b 5 reductase activity. J Clin Pharmacol 2011 (in press).","DOI":"10.1177\/0091270010393343"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chen M, Xia B, Chen B, et al. N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease. Can J Gastroenterol 21: 155-158, 2007.","DOI":"10.1155\/2007\/976804"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Naik PM, Lyon GM 3rd, Ramirez A, et al. Dapsone-induced hemolytic anemia in lung allograft recipients. J Heart Lung Transplant 27: 1198-1202, 2008.","DOI":"10.1016\/j.healun.2008.07.025"},{"key":"14","unstructured":"14. Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore) 83: 265-273, 2004."},{"key":"15","unstructured":"15. Degowin RL, Eppes RB, Powell RD, et al. The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency. Bull World Health Organ 35: 165-179, 1966."},{"key":"16","unstructured":"16. Schuurman M, van Waardenburg D, Da Costa J, et al. Severe hemolysis and methemoglobinemia following fava beans ingestion in glucose-6-phosphatase dehydrogenase deficiency: case report and literature review. Eur J Pediatr 168: 779-782, 2009."},{"key":"17","unstructured":"17. Sankoff J, Louie AD. Clinicopathologic conference: a 28-year-old woman with perioral cyanosis and low oxygen saturation. Acad Emerg Med 15: 363-367, 2008."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/15\/52_52.0247\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:46:35Z","timestamp":1621446395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/15\/52_52.0247\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":17,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.0247","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}